Trianni, Inc.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Nov 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Aug 6, 2027The maintenance fee for Enhanced Immunoglobulin Diversity (US 11,889,821) comes due Aug 6, 2027. Unpaid by Feb 7, 2028, it lapses early.
- 1 fee due Oct 2, 2027The maintenance fee for Long germline DH genes and long HCDR3 antibodies (US 11,946,063) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Aug 25 US 12,715,906 Single Chain VH and Heavy Chain Antibodies
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 10 of 10
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,881,084 | Transgenic animals and methods of use In force · USPTO record | In force | USPTO record | |
| US 10,662,256 | Transgenic mammals and methods of use thereof In force · USPTO record | In force | USPTO record | |
| US 12,096,753 | Transgenic animals and methods of use In force · USPTO record | In force | USPTO record | |
| US 12,049,516 | Transgenic mammals and methods of use thereof In force · USPTO record | In force | USPTO record | |
| US 10,813,346 | Enhanced Immunoglobulin Diversity In force · Medium confidence | In force | Medium confidence | |
| US 11,889,821 | Enhanced Immunoglobulin Diversity In force · Medium confidence | In force | Medium confidence | |
| US 11,053,288 | Enhanced production of immunoglobulins In force · USPTO record | In force | USPTO record | |
| US 11,414,478 | Single Chain VH and Heavy Chain Antibodies In force · High confidence | In force | High confidence | |
| US 11,946,063 | Long germline DH genes and long HCDR3 antibodies In force · USPTO record | In force | USPTO record | |
| US 12,715,906 | Single Chain VH and Heavy Chain Antibodies In force · High confidence | In force | High confidence |
Also on record, not counted in the 10: 2 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 9 no status recorded
Showing 1 to 10 of 14, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/440,340 | Long Germline DH Genes and Long HCDR3 Antibodies | Feb 13, 2024 | Pending |
| 18/394,651 | Enhanced Immunoglobulin Diversity | Dec 22, 2023 | Pending |
| 18/707,725 | Nov 9, 2022 | No status recorded | |
| 17/811,586 | Btla-Binding Antibodies for Modulating Immune Response and Treating Disease | Jul 10, 2022 | Pending |
| 18/557,414 | May 4, 2022 | No status recorded | |
| 18/255,525 | Heavy Chain-Only Antibodies | Dec 8, 2021 | Pending |
| 17/338,408 | Jun 3, 2021 | No status recorded | |
| 17/624,084 | Transgenic Mammals and Methods of Use Thereof | Jun 30, 2020 | Pending |
| 16/916,492 | Jun 30, 2020 | No status recorded | |
| 16/802,978 | Feb 27, 2020 | No status recorded |
10 of 14 applications shown.
Pro members see all 14 published applications.